Ferroptosis has been shown to mediate the development of fibrosis.Polyphyllin VII(PP7),a bioactive component of Paris polyphylla,exhibits potent anti-inflammatory activity and can significantly alleviate liver fibrosi...Ferroptosis has been shown to mediate the development of fibrosis.Polyphyllin VII(PP7),a bioactive component of Paris polyphylla,exhibits potent anti-inflammatory activity and can significantly alleviate liver fibrosis.In this study,treatment with PP7 significantly inhibited the proliferation and activation of hepatic stellate cells(HSCs),which could be suppressed by a ferroptosis inhibitor.In addition,it promoted HSC ferroptosis by suppressing glutathione(GSH)peroxidase 4(GPX4)and enhanced the expression of CX3C chemokine ligand 1(CX3CL1).Depletion of CX3CL1 attenuated the effects of PP7 on the activation and ferroptosis of HSCs and the expression of GPX4.Notably,CX3CL1 directly interacted with GPX4,triggering HSC ferroptosis.The transcription factor hypermethylated in cancer 1(Hic1),which binds to the Cx3cl1 promoter,increased the expression of CX3CL1.Its absence resulted in downregulation of CX3CL1,suppressing the GPX4-dependent ferroptosis of PP7-treated HSCs and promoting their activation.HIC1 was found to directly interact with PP7 at the GLY164 site.Co-culture experiments showed that PP7-induced HSC ferroptosis attenuated macrophage recruitment by regulating inflammation-related genes.HSC-specific inhibition of HIC1 counteracted PP7-induced collagen depletion and HSC ferroptosis in vivo.These findings suggest that PP7 induces HSC ferroptosis through the HIC1/CX3CL1/GPX4 axis.展开更多
Background:Radiotherapy,a primary approach in cancer treatment,damages normal cells while targeting cancer cells.Therefore,it is crucial to identify drugs with minimal side effects,high reliability,and radioprotective...Background:Radiotherapy,a primary approach in cancer treatment,damages normal cells while targeting cancer cells.Therefore,it is crucial to identify drugs with minimal side effects,high reliability,and radioprotective effects to develop novel radiotherapy strategies.Hemerocallis citrina extracts(HCE),which are derived from plants with medicinal and culinary applications,possess antioxidative and anticancer properties.Methods:In this study,we investigated the radioprotective effects of HCE on LO2 cells exposed to radiation to determine whether these effects were mediated through the nuclear factor erythroid 2–related factor 2-cystine–glutamate antiporter/glutathione peroxidase 4 pathway.Results:Cell proliferation experiments demonstrated the radioprotective effect of HCE on LO2 cells.Western blot analysis revealed that HCE regulated B-cell lymphoma protein 2-associated X,Cleaved-caspase 3,and B-cell lymphoma protein 2,thereby inhibiting radiation-induced apoptosis,which was consistent with the flow cytometry results.Conclusions:Moreover,the detection of ferroptosis-related markers indicated that HCE alleviated radiation-induced ferroptosis in LO2 cells through the nuclear factor erythroid 2–related factor 2-cystine–glutamate antiporter/glutathione peroxidase 4 pathway.These findings provide a theoretical basis for the radioprotective effects of HCE on LO2 cells and offer new insights into the development of radioprotective drugs.展开更多
Objective:To investigate potential mechanisms of anti-atherosclerosis by berberine(BBR)using ApoE-/-mice.Methods:Eight 8-week-old C57BL/6J mice were used as a blank control group(normal),and 568-week-old AopE-/-mice w...Objective:To investigate potential mechanisms of anti-atherosclerosis by berberine(BBR)using ApoE-/-mice.Methods:Eight 8-week-old C57BL/6J mice were used as a blank control group(normal),and 568-week-old AopE-/-mice were fed a high-fat diet for 12 weeks,according to a completely random method,and were divided into the model group,BBR low-dose group(50 mg/kg,BBRL),BBR medium-dose group(100 mg/kg,BBRM),BBR high-dose group(150 mg/kg,BBRH),BBR+nuclear factor erythroid 2-related factor 2(NRF2)inhibitor group(100 mg/kg BBR+30 mg/kg ML385,BBRM+ML385),NRF2 inhibitor group(30 mg/kg,ML385),and positive control group(2.5 mg/kg,atorvastatin),8 in each group.After 4 weeks of intragastric administration,samples were collected and serum,aorta,heart and liver tissues were isolated.Biochemical kits were used to detect serum lipid content and the expression levels of malondialdehyde(MDA)and superoxide dismutase(SOD)in all experimental groups.The pathological changes of atherosclerosis(AS)were observed by aorta gross Oil Red O,aortic sinus hematoxylin-eosin(HE)and Masson staining.Liver lipopathy was observed in mice by HE staining.The morphology of mitochondria in aorta cells was observed under transmission electron microscope.Flow cytometry was used to detect reactive oxygen species(ROS)expression in aorta of mice in each group.The content of ferrous ion Fe^(2+)in serum of mice was detected by biochemical kit.The mRNA and protein relative expression levels of NRF2,glutathione peroxidase 4(GPX4)and recombinant solute carrier family 7 member 11(SLC7A11)were detected by quantitative real time polymerase chain reaction(RT-q PCR)and Western blot,respectively.Results:BBRM and BBRH groups delayed the progression of AS and reduced the plaque area(P<0.01).The characteristic morphological changes of ferroptosis were rarely observed in BBR-treated AS mice,and the content of Fe^(2+)in BBR group was significantly lower than that in the model group(P<0.01).BBR decreased ROS and MDA levels in mouse aorta,increased SOD activity(P<0.01),significantly up-regulated NRF2/SLC7A11/GPX4 protein and mRNA expression levels(P<0.01),and inhibited lipid peroxidation.Compared with the model group,the body weight,blood lipid level and aortic plaque area of ML385 group increased(P<0.01);the morphology of mitochondria showed significant ferroptosis characteristics;the serum Fe^(2+),MDA and ROS levels increased(P<0.05 or P<0.01),and the activity of SOD decreased(P<0.01).Compared with BBRM group,the iron inhibition effect of BBRM+ML385 group was significantly weakened,and the plaque area significantly increased(P<0.01).Conclusion:Through NRF2/SLC7A11/GPX4 pathway,BBR can resist oxidative stress,inhibit ferroptosis,reduce plaque area,stabilize plaque,and exert anti-AS effects.展开更多
铁是几乎所有生物系统中必不可少的金属。然而,细胞内的铁含量需要严格调节,因为过量的铁会随着ROS的产生而产生破坏性影响,铁死亡是一种新型的由铁依赖性脂质过氧化作用引起的氧化调节细胞死亡。铁死亡涉及遗传、代谢和蛋白质的调节、...铁是几乎所有生物系统中必不可少的金属。然而,细胞内的铁含量需要严格调节,因为过量的铁会随着ROS的产生而产生破坏性影响,铁死亡是一种新型的由铁依赖性脂质过氧化作用引起的氧化调节细胞死亡。铁死亡涉及遗传、代谢和蛋白质的调节、触发和执行机制,在很大程度上与其他形式的受调节细胞死亡不重叠。脂质代谢对于肿瘤的增殖以及侵袭、转染都具有很重要的作用,例如细胞膜层面的高水平膜脂质与肿瘤细胞抵御活性氧(ROS)的损伤密切相关,由于高饱和度的膜脂对于氧化反应的刺激不敏感这为肿瘤细胞无形中提供了保护作用。目前主流的肿瘤化疗采用诱导凋亡的方式杀死或抑制肿瘤细胞。然而,越来越明显地是,肿瘤细胞可能对这些依赖凋亡的抗肿瘤方式表现出内在或获得性抵抗,从而大大增加了治疗失败和治疗后复发的风险。对于肿瘤而言,越来越多研究表明,在肿瘤组织中,铁死亡被显著抑制,导致了肿瘤不受控制地转移以及侵袭,这也为调节靶向肿瘤细胞的死亡对于肿瘤的免疫治疗提供了一种新的治疗方式以及为其他以异常细胞增生的疾病提供新的治疗思路。有趣的是,治疗耐药的癌细胞,特别是那些间充质状态和易于转移的癌细胞,非常容易发生铁死亡。目前许多研究证实:铁死亡与肿瘤存在密切的联系,并且涉及一系列机制,并且铁死亡还可以根除一些凋亡不敏感的肿瘤细胞,激活铁死亡途径可能是克服传统癌症治疗耐药机制的潜在策略。故此铁死亡的相关研究进展对于肿瘤的治疗而言具有重要的意义。Iron is an essential metal in almost all biological systems. However, the intracellular iron content needs to be strictly regulated because excessive iron can have destructive effects along with the generation of reactive oxygen species (ROS). Ferroptosis is a novel type of oxidative regulated cell death caused by iron-dependent lipid peroxidation. Ferroptosis involves the regulatory, triggering and execution mechanisms of genetics, metabolism and proteins, and largely does not overlap with other forms of regulated cell death. Lipid metabolism plays a very important role in the proliferation. High levels of membrane lipids at the cellular membrane level are highly correlated with the ability of tumor cells to avoid damage from reactive oxygen species (ROS). Because membrane lipids with high saturation are insensitive to the stimuli of oxidation reactions, they provide an invisible protective effect for tumor cells. Currently, the mainstream tumor chemotherapy uses the method of inducing apoptosis to kill or inhibit tumor cells. However, it is becoming increasingly evident that tumor cells may exhibit intrinsic or acquired resistance to these apoptosis-dependent anti-tumor approaches, which greatly increases the risk of treatment failure and recurrence after treatment. For tumors, more and more studies have shown that in tumor tissues, ferroptosis is significantly inhibited, leading to uncontrolled metastasis and invasion of tumors. This also provides a new treatment approach for tumor immunotherapy by regulating the death of targeted tumor cells, and offers new treatment ideas for other diseases characterized by abnormal cell proliferation. Interestingly, cancer cells resistant to treatment, especially those in a mesenchymal state and prone to metastasis, are highly susceptible to ferroptosis. Currently, many studies have confirmed that there is a close relationship between ferroptosis and tumors, involving a series of mechanisms. Moreover, ferroptosis can also eradicate some tumor cells that are insensitive to apoptosis. Activating the ferroptosis pathway may be a potential strategy to overcome the resistance mechanisms of traditional cancer treatments. Therefore, the relevant research progress of ferroptosis is of great significance for the treatment of tumors.展开更多
背景:铁死亡介导的缺血再灌注损伤对压疮的发生发展起重要作用,可能存在压疮相关的铁死亡生物标志物,但其机制尚未阐明。目的:通过生物信息学手段探讨压疮的分子机制,寻找压疮过程中铁死亡相关差异基因,为其临床治疗提供新的视角。方法...背景:铁死亡介导的缺血再灌注损伤对压疮的发生发展起重要作用,可能存在压疮相关的铁死亡生物标志物,但其机制尚未阐明。目的:通过生物信息学手段探讨压疮的分子机制,寻找压疮过程中铁死亡相关差异基因,为其临床治疗提供新的视角。方法:使用GEO数据库和FerrDb数据库下载数据集并进行预处理。对单细胞转录组测序数据进行聚类和占比分析、代谢活性和拟时序分析、细胞通讯分析、铁死亡基因集细胞识别和富集分析,确定铁死亡差异基因,并通过动物实验进一步验证。将20只SD大鼠随机分为正常组和模型组,每组10只。正常组大鼠不进行任何处理,模型组大鼠采用缺血再灌注循环周期模式制备压疮大鼠模型,采用荧光定量PCR和免疫印迹检测压疮大鼠创面组织内差异表达基因和蛋白的变化。结果与结论:(1)单细胞转录组测序数据聚类划分为6种细胞类型,压疮组2型和3型角质形成细胞占比较高。(2)不同细胞亚群之间具有明显的代谢异质性和演变轨迹。(3)2型和3型角质形成细胞在细胞通讯中作用最强,2型角质形成细胞配体-受体强度最佳。(4)2型角质形成细胞铁死亡得分较高,有显著上调或下调的差异基因,并得到27个GO富集条目、20个KEGG富集条目和24个铁死亡相关差异基因,以谷胱甘肽过氧化物酶4(glutathione peroxidase 4,GPX4)和长链酯酰辅酶A合成酶4(acyl-CoA synthetase long chain family member 4,ACSL4)为主。(5)动物实验验证了与正常组相比,模型组大鼠铁死亡抑制蛋白GPX4表达下调,铁死亡促进蛋白ACSL4表达上调。上述结果证实,压疮组织中存在铁死亡,GPX4和ACSL4为调控压疮组织中铁死亡的重要基因。展开更多
Tendinopathy is a common and complex musculoskeletal disorder,unfortunately current clinical strategies for tendinopathy have low therapeutic efficacy because of complicated pathogenesis.Oxidative stress is considered...Tendinopathy is a common and complex musculoskeletal disorder,unfortunately current clinical strategies for tendinopathy have low therapeutic efficacy because of complicated pathogenesis.Oxidative stress is considered as the major cause of tendinopathy as well as the important target,but still lacking ideal antioxidant solution.To this end,an efficient reactive oxygen species(ROS)biocatalyst,PtIrRuRhCu high-entropy alloy nanozyme(HEANZ),has been designed for treatment of tendinopathy.The non-ionic block copolymer(polyvinyl pyrrolidone)coated PtIrRuRhCu HEANZ with size of~4.0 nm exhibits good biocompatibility and multiple enzyme-like antioxidant activity(including peroxidase,catalase and superoxide dismutase(SOD)-like)to modulate ROS.The therapeutic efficacy of PtIrRuRhCu HEANZ in tendinopathy has been systematically demonstrated in vitro and in vivo.PtIrRuRhCu HEANZ can alleviate the t-Butyl hydroperoxide(TBHP)stimulated tendinopathy by clearing ROS,reducing inflammation and restoring mitochondrial autophagy.Using phosphoglycerate mutase family member 5(PGAM5)siRNA and FUN14 domain containing protein 1(FUNDC1)siRNA for intervention,we clearly revealed that PtIrRuRhCu HEANZ promots mitochondrial autophagy through upregulating the PGAM5/FUNDC1/glutathione peroxidase 4(GPX4)axis.This study provides a nanozyme strategy for the antioxidant treatment of tendinopathy and provides insights into the therapeutic mechanism.展开更多
目的:验证心肌细胞缺氧/复氧(H/R)损伤中是否有铁死亡的发生,以及探讨铁死亡抑制剂Ferrostatin-1(Fer-1)对心肌细胞H/R损伤的作用及其机制。方法:新生1~3 d SD乳鼠,提取原代心肌细胞,随机分为正常对照组(Control)、H/R组和H/R+Fer-1组。...目的:验证心肌细胞缺氧/复氧(H/R)损伤中是否有铁死亡的发生,以及探讨铁死亡抑制剂Ferrostatin-1(Fer-1)对心肌细胞H/R损伤的作用及其机制。方法:新生1~3 d SD乳鼠,提取原代心肌细胞,随机分为正常对照组(Control)、H/R组和H/R+Fer-1组。H/R组细胞培养52 h后,加入4 mmol/L Na 2 S 2 O 4溶液,缺氧1 h后,用含10%小牛血清的DMEM培养液复氧培养3 h。H/R+Fer-1组经Fer-1(2μmol/L)预处理24 h后再进行缺氧复氧处理。各组细胞应用紫外分光光度法检测乳酸脱氢酶(LDH)释放率,CCK-8法检测细胞存活率,黄嘌呤氧化酶法检测超氧化物歧化酶(SOD),化学比色法检测丙二醛(MDA),免疫荧光观测线粒体膜电位、活性氧(ROS)改变,Western blot检测铁死亡关键蛋白ACSL4、GPX4的表达。结果:与control组比较,H/R组细胞活性、SOD释放量和MMP水平均显著降低(P<0.05),LDH、MDA、ROS释放量均显著增加(P<0.05),ACSL4蛋白表达显著升高(P<0.05)、GPX4蛋白表达显著下降(P<0.05)。与H/R组比较,H/R+Fer-1组细胞活性、SOD释放量和MMP水平均显著升高(P<0.05),LDH、MDA、ROS释放量均显著降低(P<0.05),ACSL4蛋白表达显著下降(P<0.05)、GPX4蛋白表达显著升高(P<0.05)。结论:心肌细胞H/R损伤中有铁死亡的发生,Fer-1可通过调控ACSL4和GPX4抑制细胞内ROS的产生,从而减轻铁死亡引起的原代心肌细胞缺氧复氧损伤。展开更多
基金supported by the National Natural Science Foundation of China(Grant No.:81873576)Wenzhou Municipal Science and Technology Bureau,China(Grant No.:Y20220023).
文摘Ferroptosis has been shown to mediate the development of fibrosis.Polyphyllin VII(PP7),a bioactive component of Paris polyphylla,exhibits potent anti-inflammatory activity and can significantly alleviate liver fibrosis.In this study,treatment with PP7 significantly inhibited the proliferation and activation of hepatic stellate cells(HSCs),which could be suppressed by a ferroptosis inhibitor.In addition,it promoted HSC ferroptosis by suppressing glutathione(GSH)peroxidase 4(GPX4)and enhanced the expression of CX3C chemokine ligand 1(CX3CL1).Depletion of CX3CL1 attenuated the effects of PP7 on the activation and ferroptosis of HSCs and the expression of GPX4.Notably,CX3CL1 directly interacted with GPX4,triggering HSC ferroptosis.The transcription factor hypermethylated in cancer 1(Hic1),which binds to the Cx3cl1 promoter,increased the expression of CX3CL1.Its absence resulted in downregulation of CX3CL1,suppressing the GPX4-dependent ferroptosis of PP7-treated HSCs and promoting their activation.HIC1 was found to directly interact with PP7 at the GLY164 site.Co-culture experiments showed that PP7-induced HSC ferroptosis attenuated macrophage recruitment by regulating inflammation-related genes.HSC-specific inhibition of HIC1 counteracted PP7-induced collagen depletion and HSC ferroptosis in vivo.These findings suggest that PP7 induces HSC ferroptosis through the HIC1/CX3CL1/GPX4 axis.
基金supported by the Natural Science Foundation of Hunan Province(2021JJ30592)Health Commission Scientific Research Project of Hunan Province(D202309037942)+1 种基金Key Research Project of Education Department of Hunan Province(19A429)National Natural Science Foundation of China(81272994).
文摘Background:Radiotherapy,a primary approach in cancer treatment,damages normal cells while targeting cancer cells.Therefore,it is crucial to identify drugs with minimal side effects,high reliability,and radioprotective effects to develop novel radiotherapy strategies.Hemerocallis citrina extracts(HCE),which are derived from plants with medicinal and culinary applications,possess antioxidative and anticancer properties.Methods:In this study,we investigated the radioprotective effects of HCE on LO2 cells exposed to radiation to determine whether these effects were mediated through the nuclear factor erythroid 2–related factor 2-cystine–glutamate antiporter/glutathione peroxidase 4 pathway.Results:Cell proliferation experiments demonstrated the radioprotective effect of HCE on LO2 cells.Western blot analysis revealed that HCE regulated B-cell lymphoma protein 2-associated X,Cleaved-caspase 3,and B-cell lymphoma protein 2,thereby inhibiting radiation-induced apoptosis,which was consistent with the flow cytometry results.Conclusions:Moreover,the detection of ferroptosis-related markers indicated that HCE alleviated radiation-induced ferroptosis in LO2 cells through the nuclear factor erythroid 2–related factor 2-cystine–glutamate antiporter/glutathione peroxidase 4 pathway.These findings provide a theoretical basis for the radioprotective effects of HCE on LO2 cells and offer new insights into the development of radioprotective drugs.
文摘目的探究糖尿病肾病(diabetic kidney disease,DKD)血瘀证大鼠肾损害与肾脏铁死亡的潜在机制。方法将50只SPF级雄性SD大鼠分为对照组、DKD组、DKD血瘀证组。采用腹腔注射链脲佐菌素的方法复制DKD大鼠模型,采用尾静脉注射右旋糖酐的方法复制DKD血瘀证模型。实验过程中观察大鼠血瘀证表现及检测24 h尿蛋白、血清肌酐、血尿素氮、血液流变学指标,采用苏木精-伊红染色、Masson染色、PAS染色观察肾脏的组织形态,采用透射电子显微镜观察铁死亡典型细胞的线粒体变化;采用免疫组织化学法、Western blot法检测肾组织铁死亡相关蛋白[长链酯酰辅酶A合成酶4(Acyl-CoA synthetase long chain family member 4,ACSL4)、谷胱甘肽过氧化物酶4(glutathione peroxidase 4,GPX4)]及肾脏纤维化指标[纤维连接蛋白(fibronectin,FN)、Ⅳ型胶原蛋白(typeⅣcollagen,Col-Ⅳ)]的表达水平。结果与对照组比较,DKD组大鼠肾脏病理变化加重,线粒体损伤明显,24 h尿蛋白含量,血清肌酐、血尿素氮水平及全血黏度、血浆黏度明显升高(P<0.05),肾脏ACSL4、FN和Col-Ⅳ及其mRNA表达水平明显升高(P<0.05),GPX4蛋白及其mRNA表达水平明显降低(P<0.05)。DKD血瘀证大鼠出现唇色黯淡、眼球黯红、耳廓紫红、舌下脉络紫黯等血瘀证表现,24 h尿蛋白和血清肌酐、血尿素氮水平明显高于DKD组,光学显微镜下可见肾脏出现明显的系膜基质增生、肾小球萎缩、肾间质胶原沉积和纤维化,电子显微镜下可见肾组织细胞线粒体损伤明显,嵴基本断裂,ACSL4、FN、Col-Ⅳ及其mRNA表达水平较DKD组明显上升(P<0.05),GPX4蛋白及其mRNA表达水平较DKD组明显下降(P<0.05)。结论DKD血瘀证大鼠肾脏损害更加严重,其机制可能与GPX4、ACSL4介导的铁死亡有关。
基金Supported by the Henan Province Science and Technology Research Project(No.182102310093)。
文摘Objective:To investigate potential mechanisms of anti-atherosclerosis by berberine(BBR)using ApoE-/-mice.Methods:Eight 8-week-old C57BL/6J mice were used as a blank control group(normal),and 568-week-old AopE-/-mice were fed a high-fat diet for 12 weeks,according to a completely random method,and were divided into the model group,BBR low-dose group(50 mg/kg,BBRL),BBR medium-dose group(100 mg/kg,BBRM),BBR high-dose group(150 mg/kg,BBRH),BBR+nuclear factor erythroid 2-related factor 2(NRF2)inhibitor group(100 mg/kg BBR+30 mg/kg ML385,BBRM+ML385),NRF2 inhibitor group(30 mg/kg,ML385),and positive control group(2.5 mg/kg,atorvastatin),8 in each group.After 4 weeks of intragastric administration,samples were collected and serum,aorta,heart and liver tissues were isolated.Biochemical kits were used to detect serum lipid content and the expression levels of malondialdehyde(MDA)and superoxide dismutase(SOD)in all experimental groups.The pathological changes of atherosclerosis(AS)were observed by aorta gross Oil Red O,aortic sinus hematoxylin-eosin(HE)and Masson staining.Liver lipopathy was observed in mice by HE staining.The morphology of mitochondria in aorta cells was observed under transmission electron microscope.Flow cytometry was used to detect reactive oxygen species(ROS)expression in aorta of mice in each group.The content of ferrous ion Fe^(2+)in serum of mice was detected by biochemical kit.The mRNA and protein relative expression levels of NRF2,glutathione peroxidase 4(GPX4)and recombinant solute carrier family 7 member 11(SLC7A11)were detected by quantitative real time polymerase chain reaction(RT-q PCR)and Western blot,respectively.Results:BBRM and BBRH groups delayed the progression of AS and reduced the plaque area(P<0.01).The characteristic morphological changes of ferroptosis were rarely observed in BBR-treated AS mice,and the content of Fe^(2+)in BBR group was significantly lower than that in the model group(P<0.01).BBR decreased ROS and MDA levels in mouse aorta,increased SOD activity(P<0.01),significantly up-regulated NRF2/SLC7A11/GPX4 protein and mRNA expression levels(P<0.01),and inhibited lipid peroxidation.Compared with the model group,the body weight,blood lipid level and aortic plaque area of ML385 group increased(P<0.01);the morphology of mitochondria showed significant ferroptosis characteristics;the serum Fe^(2+),MDA and ROS levels increased(P<0.05 or P<0.01),and the activity of SOD decreased(P<0.01).Compared with BBRM group,the iron inhibition effect of BBRM+ML385 group was significantly weakened,and the plaque area significantly increased(P<0.01).Conclusion:Through NRF2/SLC7A11/GPX4 pathway,BBR can resist oxidative stress,inhibit ferroptosis,reduce plaque area,stabilize plaque,and exert anti-AS effects.
文摘铁是几乎所有生物系统中必不可少的金属。然而,细胞内的铁含量需要严格调节,因为过量的铁会随着ROS的产生而产生破坏性影响,铁死亡是一种新型的由铁依赖性脂质过氧化作用引起的氧化调节细胞死亡。铁死亡涉及遗传、代谢和蛋白质的调节、触发和执行机制,在很大程度上与其他形式的受调节细胞死亡不重叠。脂质代谢对于肿瘤的增殖以及侵袭、转染都具有很重要的作用,例如细胞膜层面的高水平膜脂质与肿瘤细胞抵御活性氧(ROS)的损伤密切相关,由于高饱和度的膜脂对于氧化反应的刺激不敏感这为肿瘤细胞无形中提供了保护作用。目前主流的肿瘤化疗采用诱导凋亡的方式杀死或抑制肿瘤细胞。然而,越来越明显地是,肿瘤细胞可能对这些依赖凋亡的抗肿瘤方式表现出内在或获得性抵抗,从而大大增加了治疗失败和治疗后复发的风险。对于肿瘤而言,越来越多研究表明,在肿瘤组织中,铁死亡被显著抑制,导致了肿瘤不受控制地转移以及侵袭,这也为调节靶向肿瘤细胞的死亡对于肿瘤的免疫治疗提供了一种新的治疗方式以及为其他以异常细胞增生的疾病提供新的治疗思路。有趣的是,治疗耐药的癌细胞,特别是那些间充质状态和易于转移的癌细胞,非常容易发生铁死亡。目前许多研究证实:铁死亡与肿瘤存在密切的联系,并且涉及一系列机制,并且铁死亡还可以根除一些凋亡不敏感的肿瘤细胞,激活铁死亡途径可能是克服传统癌症治疗耐药机制的潜在策略。故此铁死亡的相关研究进展对于肿瘤的治疗而言具有重要的意义。Iron is an essential metal in almost all biological systems. However, the intracellular iron content needs to be strictly regulated because excessive iron can have destructive effects along with the generation of reactive oxygen species (ROS). Ferroptosis is a novel type of oxidative regulated cell death caused by iron-dependent lipid peroxidation. Ferroptosis involves the regulatory, triggering and execution mechanisms of genetics, metabolism and proteins, and largely does not overlap with other forms of regulated cell death. Lipid metabolism plays a very important role in the proliferation. High levels of membrane lipids at the cellular membrane level are highly correlated with the ability of tumor cells to avoid damage from reactive oxygen species (ROS). Because membrane lipids with high saturation are insensitive to the stimuli of oxidation reactions, they provide an invisible protective effect for tumor cells. Currently, the mainstream tumor chemotherapy uses the method of inducing apoptosis to kill or inhibit tumor cells. However, it is becoming increasingly evident that tumor cells may exhibit intrinsic or acquired resistance to these apoptosis-dependent anti-tumor approaches, which greatly increases the risk of treatment failure and recurrence after treatment. For tumors, more and more studies have shown that in tumor tissues, ferroptosis is significantly inhibited, leading to uncontrolled metastasis and invasion of tumors. This also provides a new treatment approach for tumor immunotherapy by regulating the death of targeted tumor cells, and offers new treatment ideas for other diseases characterized by abnormal cell proliferation. Interestingly, cancer cells resistant to treatment, especially those in a mesenchymal state and prone to metastasis, are highly susceptible to ferroptosis. Currently, many studies have confirmed that there is a close relationship between ferroptosis and tumors, involving a series of mechanisms. Moreover, ferroptosis can also eradicate some tumor cells that are insensitive to apoptosis. Activating the ferroptosis pathway may be a potential strategy to overcome the resistance mechanisms of traditional cancer treatments. Therefore, the relevant research progress of ferroptosis is of great significance for the treatment of tumors.
文摘背景:铁死亡介导的缺血再灌注损伤对压疮的发生发展起重要作用,可能存在压疮相关的铁死亡生物标志物,但其机制尚未阐明。目的:通过生物信息学手段探讨压疮的分子机制,寻找压疮过程中铁死亡相关差异基因,为其临床治疗提供新的视角。方法:使用GEO数据库和FerrDb数据库下载数据集并进行预处理。对单细胞转录组测序数据进行聚类和占比分析、代谢活性和拟时序分析、细胞通讯分析、铁死亡基因集细胞识别和富集分析,确定铁死亡差异基因,并通过动物实验进一步验证。将20只SD大鼠随机分为正常组和模型组,每组10只。正常组大鼠不进行任何处理,模型组大鼠采用缺血再灌注循环周期模式制备压疮大鼠模型,采用荧光定量PCR和免疫印迹检测压疮大鼠创面组织内差异表达基因和蛋白的变化。结果与结论:(1)单细胞转录组测序数据聚类划分为6种细胞类型,压疮组2型和3型角质形成细胞占比较高。(2)不同细胞亚群之间具有明显的代谢异质性和演变轨迹。(3)2型和3型角质形成细胞在细胞通讯中作用最强,2型角质形成细胞配体-受体强度最佳。(4)2型角质形成细胞铁死亡得分较高,有显著上调或下调的差异基因,并得到27个GO富集条目、20个KEGG富集条目和24个铁死亡相关差异基因,以谷胱甘肽过氧化物酶4(glutathione peroxidase 4,GPX4)和长链酯酰辅酶A合成酶4(acyl-CoA synthetase long chain family member 4,ACSL4)为主。(5)动物实验验证了与正常组相比,模型组大鼠铁死亡抑制蛋白GPX4表达下调,铁死亡促进蛋白ACSL4表达上调。上述结果证实,压疮组织中存在铁死亡,GPX4和ACSL4为调控压疮组织中铁死亡的重要基因。
基金supported by the National Major Research plan of NSFC(No.92368201)the National Key Research and Development Program of China(No.2021YFA1201404)+2 种基金Major Project of the National Natural Science Foundation of China(No.81991514)Jiangsu Province Medical Innovation Center of Orthopedic Surgery(No.CXZX202214)Jiangsu Provincial Key Medical Center Foundation,Jiangsu Provincial Medical Outstanding Talent Foundation,Jiangsu Provincial Medical Youth Talent Foundation and Jiangsu Provincial Key Medical Talent Foundation,and the Fundamental Research Funds for the Central Universities(Nos.14380493,and 14380494).
文摘Tendinopathy is a common and complex musculoskeletal disorder,unfortunately current clinical strategies for tendinopathy have low therapeutic efficacy because of complicated pathogenesis.Oxidative stress is considered as the major cause of tendinopathy as well as the important target,but still lacking ideal antioxidant solution.To this end,an efficient reactive oxygen species(ROS)biocatalyst,PtIrRuRhCu high-entropy alloy nanozyme(HEANZ),has been designed for treatment of tendinopathy.The non-ionic block copolymer(polyvinyl pyrrolidone)coated PtIrRuRhCu HEANZ with size of~4.0 nm exhibits good biocompatibility and multiple enzyme-like antioxidant activity(including peroxidase,catalase and superoxide dismutase(SOD)-like)to modulate ROS.The therapeutic efficacy of PtIrRuRhCu HEANZ in tendinopathy has been systematically demonstrated in vitro and in vivo.PtIrRuRhCu HEANZ can alleviate the t-Butyl hydroperoxide(TBHP)stimulated tendinopathy by clearing ROS,reducing inflammation and restoring mitochondrial autophagy.Using phosphoglycerate mutase family member 5(PGAM5)siRNA and FUN14 domain containing protein 1(FUNDC1)siRNA for intervention,we clearly revealed that PtIrRuRhCu HEANZ promots mitochondrial autophagy through upregulating the PGAM5/FUNDC1/glutathione peroxidase 4(GPX4)axis.This study provides a nanozyme strategy for the antioxidant treatment of tendinopathy and provides insights into the therapeutic mechanism.
文摘目的:验证心肌细胞缺氧/复氧(H/R)损伤中是否有铁死亡的发生,以及探讨铁死亡抑制剂Ferrostatin-1(Fer-1)对心肌细胞H/R损伤的作用及其机制。方法:新生1~3 d SD乳鼠,提取原代心肌细胞,随机分为正常对照组(Control)、H/R组和H/R+Fer-1组。H/R组细胞培养52 h后,加入4 mmol/L Na 2 S 2 O 4溶液,缺氧1 h后,用含10%小牛血清的DMEM培养液复氧培养3 h。H/R+Fer-1组经Fer-1(2μmol/L)预处理24 h后再进行缺氧复氧处理。各组细胞应用紫外分光光度法检测乳酸脱氢酶(LDH)释放率,CCK-8法检测细胞存活率,黄嘌呤氧化酶法检测超氧化物歧化酶(SOD),化学比色法检测丙二醛(MDA),免疫荧光观测线粒体膜电位、活性氧(ROS)改变,Western blot检测铁死亡关键蛋白ACSL4、GPX4的表达。结果:与control组比较,H/R组细胞活性、SOD释放量和MMP水平均显著降低(P<0.05),LDH、MDA、ROS释放量均显著增加(P<0.05),ACSL4蛋白表达显著升高(P<0.05)、GPX4蛋白表达显著下降(P<0.05)。与H/R组比较,H/R+Fer-1组细胞活性、SOD释放量和MMP水平均显著升高(P<0.05),LDH、MDA、ROS释放量均显著降低(P<0.05),ACSL4蛋白表达显著下降(P<0.05)、GPX4蛋白表达显著升高(P<0.05)。结论:心肌细胞H/R损伤中有铁死亡的发生,Fer-1可通过调控ACSL4和GPX4抑制细胞内ROS的产生,从而减轻铁死亡引起的原代心肌细胞缺氧复氧损伤。
